NS · Healthcare

Jenburkt Pharmaceuticals Ltd (524731)

Pharmaceuticals & Biotechnology

Jenburkt Pharmaceuticals Ltd (524731) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $4.98B, P/E ratio is 14.33, net margin is 19.1%, dividend yield is 1.60%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 524731

Market cap

$4.98B

P/E ratio

14.33

Net margin

19.1%

Dividend yield

1.60%

Jenburkt Pharmaceuticals Ltd (524731) — FAQ

What is Jenburkt Pharmaceuticals Ltd's market cap?

Jenburkt Pharmaceuticals Ltd (524731) has a reported market cap of $4.98B (data as of 2026-07-10).

What is 524731's P/E ratio?

The price-to-earnings (P/E) ratio for Jenburkt Pharmaceuticals Ltd (524731) is 14.33 (data as of 2026-07-10).

Does Jenburkt Pharmaceuticals Ltd pay a dividend?

Jenburkt Pharmaceuticals Ltd (524731) shows a reported dividend yield of 1.60%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Jenburkt Pharmaceuticals Ltd in?

Jenburkt Pharmaceuticals Ltd (524731) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 524731 listed on?

524731 is listed on NS.

What is Jenburkt Pharmaceuticals Ltd's net margin?

Jenburkt Pharmaceuticals Ltd (524731) reports a net margin of 19.1% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)